No data to
display.
Moderna, Inc. revenue increases to $1,862 million in quarter ended Mar 31, 2023 from previous quarter
By NewsInMinutes on May 06, 2023 | 05:36 AM IST
| Current Reporting | Revenue | Net Income | Profit/Loss |
|---|---|---|---|
| Mar 2023 | $1,862 million | $79 million | profit |
| Sep 2022 | $3,364 million | $1,043 million | profit |
| Jun 2022 | $4,749 million | $2,197 million | profit |
Moderna, Inc. [MRNA] has reported $79 million profit for the fiscal quarter ending Mar 31, 2023 while the earnings for the same period were $0.19 per share.
Revenue for the quarter was $1,862 million with operating income of $366 million.
The Cambridge, Massachusetts (MA)-based company operating in the biological products, except diagnostic substances sector has total shareholders equity of $18,863 million.
Also read:
This is a developing story. Click here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts here.